Diminished matrix metalloproteinase 9 secretion in human immunodeficiency virus-infected mononuclear phagocytes: modulation of innate immunity and implications for neurological disease

被引:29
作者
Ciborowski, P [1 ]
Enose, Y
Mack, A
Fladseth, M
Gendelman, HE
机构
[1] Univ Nebraska, Med Ctr, Ctr Neurovirol & Neurodegenerat Disorders, Nebraska Med Ctr 985215, Omaha, NE 68198 USA
[2] Univ Nebraska, Med Ctr, Dept Biochem & Mol Biol, Omaha, NE 68198 USA
[3] Univ Nebraska, Med Ctr, Dept Pharmacol, Omaha, NE 68198 USA
[4] Univ Nebraska, Med Ctr, Dept Internal Med, Omaha, NE 68198 USA
关键词
proteomics; monocyte-derived macrophages; human immunodeficiency virus; HIV-1-associated dementia; matrix metalloproteinases;
D O I
10.1016/j.jneuroim.2004.08.033
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Neurotoxic secretory products from virus-infected mononuclear phagocytes (MP; perivascular macrophages and microglia) orchestrate the neuropathogenesis of human immunodeficiency virus type one (HIV-1) infection. To uncover such MP products and their relationship to disease, we used a proteomics platform consisting of one dimensional polyacrylamide gel electrophoresis (1-DE), mass spectrometry peptide sequencing, and bioinformatics in order to identify from HIV-1-infected monocyte-derived macrophages (MDM) secretions. Matrix metalloproteinase 9 (MMP 9) secreted in abundance in MDM was markedly down-regulated following viral infection. A negative correlation between MMP 9 and HIV-1 reverse transcriptase activity was shown by quantitative Western blot assays. These data further demonstrate immunoregulatory activities of HIV-1-infected MDM providing unique insights into cellular function in disease. (C) 2004 Elsevier B.V. All rights reserved.
引用
收藏
页码:11 / 16
页数:6
相关论文
共 20 条
[1]   HIV-1-associated dementia: A metabolic encephalopathy perpetrated by virus-infected and immune-competent mononuclear phagocytes [J].
Anderson, E ;
Zink, W ;
Xiong, HG ;
Gendelman, HE .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 :S43-S54
[2]   PLATELET-ACTIVATING-FACTOR - A CANDIDATE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INDUCED NEUROTOXIN [J].
GELBARD, HA ;
NOTTET, HSLM ;
SWINDELLS, S ;
JETT, M ;
DZENKO, KA ;
GENIS, P ;
WHITE, R ;
WANG, L ;
CHOI, YB ;
ZHANG, DX ;
LIPTON, SA ;
TOURTELLOTTE, WW ;
EPSTEIN, LG ;
GENDELMAN, HE .
JOURNAL OF VIROLOGY, 1994, 68 (07) :4628-4635
[3]   EFFICIENT ISOLATION AND PROPAGATION OF HUMAN IMMUNODEFICIENCY VIRUS ON RECOMBINANT COLONY-STIMULATING FACTOR-1-TREATED MONOCYTES [J].
GENDELMAN, HE ;
ORENSTEIN, JM ;
MARTIN, MA ;
FERRUA, C ;
MITRA, R ;
PHIPPS, T ;
WAHL, LA ;
LANE, HC ;
FAUCI, AS ;
BURKE, DS ;
SKILLMAN, D ;
MELTZER, MS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1988, 167 (04) :1428-1441
[4]   Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in human immunodeficiency virus-associated dementia [J].
Gendelman, HE ;
Zheng, JL ;
Coulter, CL ;
Ghorpade, A ;
Che, M ;
Thylin, M ;
Rubocki, R ;
Persidsky, Y ;
Hahn, F ;
Reinhard, J ;
Swindells, S .
JOURNAL OF INFECTIOUS DISEASES, 1998, 178 (04) :1000-1007
[5]   IMMUNOCYTOCHEMICAL QUANTITATION OF HUMAN-IMMUNODEFICIENCY-VIRUS IN THE BRAIN - CORRELATIONS WITH DEMENTIA [J].
GLASS, JD ;
FEDOR, H ;
WESSELINGH, SL ;
MCARTHUR, JC .
ANNALS OF NEUROLOGY, 1995, 38 (05) :755-762
[6]   Microglia, macrophages, perivascular macrophages, and pericytes: a review of function and identification [J].
Guillemin, GJ ;
Brew, BJ .
JOURNAL OF LEUKOCYTE BIOLOGY, 2004, 75 (03) :388-397
[7]   HUMAN IMMUNODEFICIENCY VIRUS (HIV) INFECTION AND THE NERVOUS-SYSTEM - REPORT FROM THE AMERICAN-ACADEMY-OF-NEUROLOGY AIDS TASK-FORCE [J].
JANSSEN, RS .
NEUROLOGY, 1989, 39 (01) :119-122
[8]  
KALTER DC, 1991, J IMMUNOL, V146, P298
[9]   Role of matrix metalloproteinases in delayed neuronal damage after transient global cerebral ischemia [J].
Lee, SR ;
Tsuji, K ;
Lee, SR ;
Lo, EH .
JOURNAL OF NEUROSCIENCE, 2004, 24 (03) :671-678
[10]   Human immunodeficiency virus-associated dementia: An evolving disease [J].
McArthur, JC ;
Haughey, N ;
Gartner, S ;
Conant, K ;
Pardo, C ;
Nath, A ;
Sacktor, N .
JOURNAL OF NEUROVIROLOGY, 2003, 9 (02) :205-221